Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition

Frank Köster, Jörg B. Engel, Andrew V. Schally, Arnd Hönig, Andreas Schröer, Stephan Seitz, Florian Hohla, Olaf Ortmann, Klaus Diedrich, Stefan Buchholz

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint Dive into the research topics of 'Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition'. Together they form a unique fingerprint.

Medicine & Life Sciences